AZTREONAM

AZTREONAM was reported 7213 times

AZTREONAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 851 0.1562
1 CYSTIC FIBROSIS HEPATIC DISEASE 3 0.1304
2 CYSTIC FIBROSIS RELATED DIABETES 15 0.1027
3 BACTERIAL DISEASE CARRIER 72 0.0988
4 ADRENERGIC SYNDROME 7 0.0864
5 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 64 0.0717
6 ADVERSE EVENT FOLLOWING IMMUNISATION 4 0.0714
7 DISTAL INTESTINAL OBSTRUCTION SYNDROME 24 0.0712
8 BRONCHIAL SECRETION RETENTION 77 0.0604
9 INFECTIVE EXACERBATION OF BRONCHIECTASIS 17 0.0554
10 CYSTIC FIBROSIS LUNG 7 0.0547
11 CYSTIC FIBROSIS 287 0.0518
12 SUPERINFECTION 73 0.0486
13 PSEUDOMONAS BRONCHITIS 3 0.0435
14 PENICILLIUM INFECTION 6 0.0333
15 PULMONARY FUNCTION TEST DECREASED 137 0.0313
16 STENOTROPHOMONAS TEST POSITIVE 4 0.0299
17 FUNGAL DISEASE CARRIER 3 0.0297
18 HYPNOPOMPIC HALLUCINATION 3 0.0242
19 SPUTUM INCREASED 52 0.0240
20 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
21 BANDAEMIA 3 0.0204
22 DISSEMINATED MUCORMYCOSIS 8 0.0203
23 SLEEP PHASE RHYTHM DISTURBANCE 3 0.0200
24 SINUS OPERATION 47 0.0197
25 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 8 0.0197
26 PSEUDOMONAS TEST POSITIVE 15 0.0183
27 BURKHOLDERIA CEPACIA COMPLEX INFECTION 5 0.0175
28 PNEUMONIA PSEUDOMONAL 26 0.0169
29 PANCREATIC INSUFFICIENCY 6 0.0168
30 HER2 POSITIVE BREAST CANCER 6 0.0160
31 VANCOMYCIN INFUSION REACTION 6 0.0159
32 INCREASED VISCOSITY OF BRONCHIAL SECRETION 10 0.0157
33 GRANULOCYTOSIS 3 0.0153
34 NEPHRITIS ALLERGIC 6 0.0151
35 GRAM STAIN POSITIVE 3 0.0146
36 FORCED EXPIRATORY VOLUME DECREASED 41 0.0145
37 RADIATION ASSOCIATED PAIN 3 0.0144
38 COMPLICATIONS OF TRANSPLANTED LUNG 4 0.0130
39 BRONCHIAL HAEMORRHAGE 4 0.0128
40 BRONCHOSCOPY 3 0.0127
41 LUNG TRANSPLANT 44 0.0124
42 SPUTUM ABNORMAL 8 0.0121
43 INFECTED NEOPLASM 3 0.0120
44 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 11 0.0119
45 PSEUDOMONAS INFECTION 100 0.0116
46 PRODUCT CLOSURE REMOVAL DIFFICULT 11 0.0108
47 EOSINOPHILIA 187 0.0107
48 CARDIAC VALVE VEGETATION 5 0.0103
49 PRE-EXISTING DISEASE 5 0.0103
50 LABORATORY TEST INTERFERENCE 8 0.0102
51 PANCREATIC FAILURE 18 0.0102
52 RESPIRATORY TRACT INFECTION BACTERIAL 5 0.0100
53 SCOLIOSIS 61 0.0098
54 CLUBBING 4 0.0098
55 BLOOD BETA-D-GLUCAN INCREASED 3 0.0098
56 FUNGAL SEPSIS 8 0.0096
57 DEVICE RELATED THROMBOSIS 9 0.0091
58 PRODUCT PACKAGE ASSOCIATED INJURY 20 0.0090
59 RED MAN SYNDROME 7 0.0080
60 EPSTEIN-BARR VIRUS TEST POSITIVE 5 0.0079
61 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 3 0.0079
62 ENTEROCOCCAL BACTERAEMIA 8 0.0075
63 ATELECTASIS 72 0.0074
64 VESTIBULAR DISORDER 9 0.0073
65 CANDIDA TEST POSITIVE 3 0.0072
66 STAPHYLOCOCCUS TEST POSITIVE 15 0.0071
67 HAEMOPTYSIS 192 0.0069
68 BRONCHOSPASM 98 0.0069
69 RASH MORBILLIFORM 19 0.0068
70 BRONCHIECTASIS 46 0.0068
71 NONSPECIFIC REACTION 37 0.0067
72 STENOTROPHOMONAS INFECTION 9 0.0066
73 NASAL INFLAMMATION 7 0.0066
74 CARBON DIOXIDE INCREASED 9 0.0066
75 BLOOD BILIRUBIN DECREASED 4 0.0065
76 SKIN TEST POSITIVE 6 0.0064
77 PROTHROMBIN TIME RATIO DECREASED 4 0.0064
78 MULTIPLE-DRUG RESISTANCE 19 0.0061
79 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
80 RESPIRATORY TRACT INFECTION FUNGAL 3 0.0057
81 BRONCHIAL WALL THICKENING 4 0.0056
82 RETINOPATHY OF PREMATURITY 3 0.0054
83 CHOLESTATIC LIVER INJURY 12 0.0054
84 LUNG INFECTION PSEUDOMONAL 3 0.0054
85 PULMONARY FUNCTION TEST ABNORMAL 8 0.0051
86 DRUG ADMINISTERED IN WRONG DEVICE 5 0.0051
87 PATHOGEN RESISTANCE 46 0.0050
88 SPIROMETRY ABNORMAL 3 0.0050
89 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 85 0.0050
90 BRONCHOPULMONARY DYSPLASIA 4 0.0050
91 PANCREATITIS RELAPSING 4 0.0049
92 LUNG INFECTION 74 0.0048
93 PULMONARY HAEMORRHAGE 37 0.0047
94 HEPATIC CYTOLYSIS 60 0.0047
95 TOXIC EPIDERMAL NECROLYSIS 71 0.0047
96 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 120 0.0047
97 ALLERGIC OEDEMA 3 0.0046
98 MUCORMYCOSIS 12 0.0046
99 ABDOMINAL SEPSIS 4 0.0045
100 CLOSTRIDIUM TEST POSITIVE 10 0.0045
101 PNEUMOTHORAX SPONTANEOUS 3 0.0044
102 INCREASED BRONCHIAL SECRETION 11 0.0043
103 STAPHYLOCOCCAL SEPSIS 21 0.0042
104 LINEAR IGA DISEASE 7 0.0042
105 OTITIS EXTERNA 5 0.0041
106 PSEUDOMEMBRANOUS COLITIS 9 0.0040
107 EMPYEMA 8 0.0040
108 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
109 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
110 POLYHYDRAMNIOS 4 0.0039
111 RASH MACULO-PAPULAR 86 0.0039
112 RESPIRATORY TRACT IRRITATION 4 0.0038
113 OBLITERATIVE BRONCHIOLITIS 5 0.0038
114 PNEUMONIA FUNGAL 15 0.0038
115 SPUTUM DISCOLOURED 36 0.0038
116 GASTROENTERITIS NOROVIRUS 5 0.0038
117 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
118 SPUTUM CULTURE POSITIVE 3 0.0037
119 VASOPLEGIA SYNDROME 6 0.0037
120 IMMUNOGLOBULINS DECREASED 5 0.0036
121 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
122 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
123 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
124 PSEUDOMONAL BACTERAEMIA 3 0.0035
125 RESPIRATION ABNORMAL 24 0.0035
126 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
127 AXONAL NEUROPATHY 3 0.0034
128 SINUS DISORDER 68 0.0034
129 PROCALCITONIN INCREASED 4 0.0034
130 WEIGHT ABNORMAL 8 0.0033
131 DISEASE COMPLICATION 15 0.0033
132 RIB FRACTURE 67 0.0033
133 CHRONIC SINUSITIS 12 0.0032
134 TOXIC SKIN ERUPTION 32 0.0032
135 BRAIN STEM HAEMORRHAGE 3 0.0032
136 RESPIRATORY SYMPTOM 9 0.0032
137 ELECTROCARDIOGRAM CHANGE 3 0.0032
138 ENTEROCOCCAL INFECTION 15 0.0031
139 RHINOVIRUS INFECTION 12 0.0031
140 PRODUCT PACKAGING DIFFICULT TO OPEN 8 0.0031
141 HYPOVITAMINOSIS 4 0.0030
142 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
143 MIXED LIVER INJURY 9 0.0030
144 LEUKOCYTOSIS 54 0.0030
145 ACUTE PROMYELOCYTIC LEUKAEMIA 3 0.0029
146 AGRANULOCYTOSIS 54 0.0029
147 EOSINOPHIL COUNT INCREASED 24 0.0029
148 GLUCOSE TOLERANCE IMPAIRED 17 0.0029
149 LUNG ABSCESS 6 0.0029
150 TRACHEOSTOMY 4 0.0028
151 BACTERIAL SEPSIS 9 0.0028
152 PRODUCTIVE COUGH 130 0.0027
153 PERIRECTAL ABSCESS 3 0.0027
154 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
155 STEATORRHOEA 7 0.0026
156 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 6 0.0026
157 IMPAIRED QUALITY OF LIFE 37 0.0026
158 SYSTEMIC MYCOSIS 3 0.0026
159 HOSPITALISATION 394 0.0026
160 FUNGAEMIA 4 0.0025
161 DRUG RESISTANCE 65 0.0025
162 DRUG SCREEN FALSE POSITIVE 7 0.0025
163 SEPTIC SHOCK 109 0.0025
164 CRYPTOCOCCOSIS 4 0.0025
165 HYPERTRANSAMINASAEMIA 17 0.0024
166 ACUTE RESPIRATORY FAILURE 47 0.0024
167 PULMONARY PAIN 7 0.0024
168 NASAL PRURITUS 3 0.0024
169 WHEEZING 141 0.0024
170 RESPIRATORY FAILURE 173 0.0024
171 BRAIN ABSCESS 6 0.0024
172 APPENDICITIS PERFORATED 6 0.0024
173 PARANASAL SINUS HYPERSECRETION 9 0.0024
174 ACNE CYSTIC 7 0.0023
175 HYPERCAPNIA 7 0.0023
176 EMERGENCY CARE 7 0.0023
177 CARDIOPULMONARY FAILURE 9 0.0023
178 DRUG CLEARANCE DECREASED 3 0.0023
179 MITRAL VALVE DISEASE 4 0.0023
180 HEPATOCELLULAR INJURY 32 0.0023
181 EOSINOPHILIC PNEUMONIA 7 0.0022
182 PNEUMONIA VIRAL 7 0.0022
183 PLEURITIC PAIN 6 0.0022
184 RHONCHI 3 0.0022
185 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
186 CHOLESTASIS 41 0.0021
187 MECHANICAL VENTILATION 4 0.0021
188 BLOOD ALKALINE PHOSPHATASE INCREASED 52 0.0021
189 LONG QT SYNDROME 5 0.0021
190 RALES 12 0.0021
191 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
192 SLEEP PARALYSIS 3 0.0020
193 PNEUMOTHORAX 32 0.0020
194 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
195 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
196 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
197 INFECTIOUS PLEURAL EFFUSION 3 0.0020
198 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 94 0.0020
199 ENDOCARDITIS 10 0.0019
200 RENAL TUBULAR NECROSIS 19 0.0019
201 BLOOD CREATININE DECREASED 6 0.0019
202 MULTI-ORGAN FAILURE 33 0.0019
203 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
204 ASPERGILLUS INFECTION 12 0.0018
205 NASAL POLYPS 9 0.0018
206 SHOCK 42 0.0018
207 HYPERVOLAEMIA 9 0.0018
208 NOSOCOMIAL INFECTION 4 0.0018
209 LACERATION 17 0.0018
210 HYPERNATRAEMIA 9 0.0018
211 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
212 ENTEROBACTER INFECTION 3 0.0018
213 INFECTIOUS MONONUCLEOSIS 4 0.0018
214 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
215 INFECTION 254 0.0018
216 ACUTE SINUSITIS 3 0.0017
217 BLOOD CHLORIDE INCREASED 3 0.0017
218 LOCALISED OEDEMA 8 0.0017
219 PSEUDOMONAL SEPSIS 3 0.0017
220 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
221 NECROTISING FASCIITIS 6 0.0017
222 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
223 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
224 OBSESSIVE THOUGHTS 3 0.0017
225 CENTRAL VENOUS CATHETERISATION 5 0.0017
226 DERMATITIS BULLOUS 12 0.0017
227 STAPHYLOCOCCAL INFECTION 54 0.0016
228 TRANSPLANT FAILURE 4 0.0016
229 SINUS CONGESTION 22 0.0016
230 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
231 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
232 CANDIDA INFECTION 27 0.0016
233 DERMATITIS EXFOLIATIVE 8 0.0016
234 SECRETION DISCHARGE 20 0.0016
235 HYPERPARATHYROIDISM SECONDARY 4 0.0016
236 SYSTEMIC CANDIDA 4 0.0016
237 PANCREATIC CYST 3 0.0016
238 ABDOMINAL INFECTION 4 0.0016
239 HEPATIC MASS 3 0.0016
240 AORTIC ARTERIOSCLEROSIS 4 0.0016
241 LUNG DISORDER 75 0.0015
242 EXFOLIATIVE RASH 4 0.0015
243 HYPOXIA 53 0.0015
244 HYPOPHYSITIS 3 0.0015
245 TREATMENT NONCOMPLIANCE 81 0.0015
246 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
247 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
248 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
249 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
250 NEUTROPENIC COLITIS 3 0.0014
251 HYPERBILIRUBINAEMIA 15 0.0014
252 RESPIRATORY TRACT CONGESTION 23 0.0014
253 BACTERIAL INFECTION 27 0.0014
254 PULMONARY CONGESTION 19 0.0014
255 AGGRESSION 71 0.0014
256 PNEUMONIA BACTERIAL 13 0.0014
257 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
258 BLOOD ALBUMIN DECREASED 11 0.0014
259 CHEST DISCOMFORT 140 0.0014
260 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
261 HEPATITIS FULMINANT 4 0.0013
262 RHINITIS ALLERGIC 6 0.0013
263 PARESIS 3 0.0013
264 SINUS HEADACHE 8 0.0013
265 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
266 PARANASAL SINUS DISCOMFORT 5 0.0013
267 TENDON PAIN 10 0.0013
268 APHONIA 18 0.0013
269 SINUS PAIN 3 0.0013
270 COUGH 359 0.0013
271 ORAL INFECTION 5 0.0013
272 ESCHERICHIA BACTERAEMIA 3 0.0013
273 RESPIRATORY DISTRESS 35 0.0013
274 NEUTROPENIC SEPSIS 9 0.0013
275 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
276 BILE DUCT STONE 4 0.0013
277 MALNUTRITION 14 0.0013
278 LUNG INFILTRATION 11 0.0012
279 PURPURA 11 0.0012
280 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
281 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
282 BREATH ODOUR 3 0.0012
283 BRONCHITIS CHRONIC 3 0.0012
284 HAEMOLYTIC ANAEMIA 11 0.0012
285 GLOMERULONEPHRITIS 3 0.0012
286 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
287 PERSECUTORY DELUSION 3 0.0012
288 GASTROINTESTINAL TUBE INSERTION 3 0.0012
289 COAGULOPATHY 20 0.0012
290 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 85 0.0012
291 UROSEPSIS 11 0.0012
292 TONGUE ULCERATION 4 0.0012
293 HAEMODYNAMIC INSTABILITY 9 0.0012
294 BUNDLE BRANCH BLOCK LEFT 5 0.0012
295 VIRAL INFECTION 39 0.0012
296 PURULENT DISCHARGE 5 0.0012
297 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
298 FAILURE TO THRIVE 6 0.0012
299 APLASTIC ANAEMIA 6 0.0011
300 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
301 HYPERSENSITIVITY VASCULITIS 3 0.0011
302 ASTHMA 128 0.0011
303 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
304 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
305 ALANINE AMINOTRANSFERASE INCREASED 69 0.0011
306 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
307 HYPERLACTACIDAEMIA 3 0.0011
308 CIRCULATORY COLLAPSE 19 0.0011
309 GRAFT VERSUS HOST DISEASE 8 0.0011
310 ABNORMAL FAECES 9 0.0011
311 ESCHERICHIA INFECTION 9 0.0011
312 THROMBOCYTOSIS 4 0.0011
313 RED BLOOD CELL COUNT INCREASED 3 0.0011
314 NEPHROGENIC ANAEMIA 5 0.0011
315 TRANSAMINASES INCREASED 24 0.0011
316 THROMBOCYTOPENIA 120 0.0011
317 RESPIRATORY DISORDER 32 0.0011
318 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
319 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
320 SMALL INTESTINAL OBSTRUCTION 13 0.0011
321 GENERALISED ERYTHEMA 6 0.0011
322 CARDIAC FAILURE ACUTE 7 0.0010
323 ACIDOSIS 8 0.0010
324 EXERCISE TOLERANCE DECREASED 6 0.0010
325 STEVENS-JOHNSON SYNDROME 23 0.0010
326 HAEMOTHORAX 3 0.0010
327 RASH VESICULAR 5 0.0010
328 BREATH SOUNDS ABNORMAL 5 0.0010
329 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
330 HEART RATE INCREASED 100 0.0010
331 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
332 CREPITATIONS 3 0.0010
333 PREMATURE DELIVERY 16 0.0010
334 SEPSIS 112 0.0010
335 BLOOD CULTURE POSITIVE 3 0.0010
336 METABOLIC ENCEPHALOPATHY 3 0.0010
337 CANDIDIASIS 4 0.0010
338 CYSTITIS HAEMORRHAGIC 4 0.0010
339 MYASTHENIA GRAVIS 8 0.0010
340 END STAGE RENAL DISEASE 18 0.0010
341 KERATITIS 3 0.0010
342 INSURANCE ISSUE 15 0.0010
343 LIVER FUNCTION TEST INCREASED 21 0.0010
344 PORTAL HYPERTENSION 3 0.0010
345 INFLUENZA 108 0.0010
346 SOCIAL PROBLEM 4 0.0010
347 DRUG ERUPTION 17 0.0010
348 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
349 FACE OEDEMA 16 0.0009
350 ACUTE KIDNEY INJURY 145 0.0009
351 ELECTROLYTE IMBALANCE 11 0.0009
352 LIP OEDEMA 4 0.0009
353 PNEUMONIA 303 0.0009
354 BACTERAEMIA 11 0.0009
355 THROMBOTIC MICROANGIOPATHY 9 0.0009
356 RESPIRATORY TRACT INFECTION 24 0.0009
357 LYMPHOPENIA 13 0.0009
358 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
359 ATRIAL FIBRILLATION 89 0.0009
360 LIPASE INCREASED 7 0.0009
361 DRUG LEVEL INCREASED 15 0.0009
362 CYTOLYTIC HEPATITIS 3 0.0009
363 RENAL FAILURE 120 0.0009
364 STREPTOCOCCAL INFECTION 5 0.0009
365 MENINGITIS 6 0.0009
366 ANXIETY DISORDER 3 0.0009
367 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
368 AFFECTIVE DISORDER 7 0.0009
369 DRUG INTOLERANCE 86 0.0009
370 BK VIRUS INFECTION 3 0.0009
371 FEBRILE NEUTROPENIA 59 0.0009
372 IRON DEFICIENCY 4 0.0009
373 CHOLECYSTITIS ACUTE 5 0.0009
374 VASCULAR DEVICE INFECTION 4 0.0009
375 BLOOD CREATININE ABNORMAL 3 0.0009
376 LARGE INTESTINE PERFORATION 6 0.0009
377 PYREXIA 297 0.0009
378 GENERAL PHYSICAL HEALTH DETERIORATION 99 0.0009
379 BLOOD TEST ABNORMAL 12 0.0009
380 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
381 DEPRESSIVE SYMPTOM 3 0.0009
382 RASH GENERALISED 22 0.0008
383 VENTRICULAR TACHYCARDIA 14 0.0008
384 APPENDICECTOMY 3 0.0008
385 BLOOD UREA INCREASED 14 0.0008
386 APPARENT DEATH 3 0.0008
387 LIVER TRANSPLANT 3 0.0008
388 ILLNESS 85 0.0008
389 HORMONE LEVEL ABNORMAL 4 0.0008
390 BLOOD BILIRUBIN INCREASED 22 0.0008
391 ANURIA 7 0.0008
392 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
393 TACHYPNOEA 11 0.0008
394 OLIGURIA 5 0.0008
395 URINE OUTPUT DECREASED 7 0.0008
396 BRAIN INJURY 8 0.0008
397 HYPOCALCAEMIA 15 0.0008
398 KLEBSIELLA INFECTION 4 0.0008
399 DYSPNOEA 447 0.0008
400 HYPERTHERMIA 6 0.0008
401 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
402 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
403 OXYGEN SATURATION DECREASED 44 0.0008
404 THROAT IRRITATION 35 0.0008
405 INTESTINAL OBSTRUCTION 29 0.0008
406 CARDIOGENIC SHOCK 11 0.0008
407 MALABSORPTION 4 0.0008
408 RESPIRATORY ACIDOSIS 3 0.0008
409 HEPATIC ENZYME INCREASED 52 0.0008
410 SUDDEN DEATH 8 0.0008
411 RENAL FAILURE ACUTE 32 0.0008
412 RHINITIS 6 0.0007
413 C-REACTIVE PROTEIN INCREASED 27 0.0007
414 ILL-DEFINED DISORDER 45 0.0007
415 POSTOPERATIVE WOUND INFECTION 5 0.0007
416 EXPOSURE DURING PREGNANCY 46 0.0007
417 ENCEPHALOPATHY 18 0.0007
418 FUNGAL INFECTION 24 0.0007
419 FORMICATION 5 0.0007
420 CONDITION AGGRAVATED 218 0.0007
421 ATRIAL SEPTAL DEFECT 6 0.0007
422 EXTRASYSTOLES 5 0.0007
423 HAEMODIALYSIS 6 0.0007
424 MUSCULOSKELETAL CHEST PAIN 11 0.0007
425 HYPERPYREXIA 3 0.0007
426 MUSCLE FATIGUE 3 0.0007
427 THERMAL BURN 5 0.0007
428 ABSCESS LIMB 3 0.0007
429 PRODUCT CONTAINER ISSUE 6 0.0007
430 PNEUMONITIS 19 0.0007
431 ENTEROCOLITIS 4 0.0007
432 DEAFNESS 18 0.0007
433 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
434 HYPERTRIGLYCERIDAEMIA 4 0.0007
435 NASAL CONGESTION 40 0.0007
436 ABDOMINAL ABSCESS 3 0.0007
437 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
438 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
439 PLEURISY 4 0.0007
440 PETECHIAE 7 0.0007
441 PROTHROMBIN TIME PROLONGED 4 0.0007
442 HYDRONEPHROSIS 5 0.0007
443 HEPATITIS CHOLESTATIC 4 0.0007
444 OSTEOMYELITIS 12 0.0007
445 PANCYTOPENIA 37 0.0007
446 ABDOMINAL HERNIA 3 0.0007
447 LIVER FUNCTION TEST ABNORMAL 19 0.0007
448 LIVER INJURY 16 0.0007
449 RENAL FAILURE CHRONIC 5 0.0006
450 DEVICE RELATED INFECTION 10 0.0006
451 LARYNGEAL OEDEMA 4 0.0006
452 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
453 ANHEDONIA 17 0.0006
454 ERYTHEMA MULTIFORME 6 0.0006
455 BLOOD CREATININE INCREASED 42 0.0006
456 HYPOALBUMINAEMIA 5 0.0006
457 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
458 TORSADE DE POINTES 5 0.0006
459 INFUSION SITE SWELLING 4 0.0006
460 DIALYSIS 9 0.0006
461 PULSE ABSENT 3 0.0006
462 HEPATIC FAILURE 19 0.0006
463 GESTATIONAL DIABETES 3 0.0006
464 ENDOMETRIOSIS 3 0.0006
465 INCREASED APPETITE 12 0.0006
466 PALLOR 17 0.0006
467 NEPHROPATHY TOXIC 7 0.0006
468 HEPATITIS ACUTE 4 0.0006
469 HERPES SIMPLEX 4 0.0006
470 INCORRECT DOSAGE ADMINISTERED 3 0.0006
471 CHOLECYSTECTOMY 7 0.0006
472 HEPATOMEGALY 6 0.0006
473 TACHYCARDIA 54 0.0006
474 LIGAMENT SPRAIN 6 0.0006
475 PALPITATIONS 71 0.0006
476 MUCOUS STOOLS 3 0.0006
477 ABDOMINAL TENDERNESS 3 0.0006
478 CYTOKINE RELEASE SYNDROME 12 0.0006
479 CHOLECYSTITIS CHRONIC 4 0.0006
480 ANXIETY 170 0.0006
481 POST-TRAUMATIC STRESS DISORDER 4 0.0006
482 HYPOTHERMIA 6 0.0006
483 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
484 THROAT TIGHTNESS 16 0.0006
485 DRY THROAT 6 0.0006
486 DRUG LEVEL DECREASED 6 0.0006
487 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
488 RASH ERYTHEMATOUS 28 0.0006
489 HYPOKALAEMIA 27 0.0006
490 BLOOD PRESSURE INCREASED 89 0.0006
491 ANAPHYLACTIC REACTION 32 0.0006
492 HYPOMAGNESAEMIA 8 0.0006
493 PARTIAL SEIZURES 3 0.0006
494 FOLLICULITIS 6 0.0006
495 RENAL IMPAIRMENT 48 0.0006
496 MYALGIA 97 0.0006
497 HYPERKALAEMIA 20 0.0006
498 BLOOD LACTIC ACID INCREASED 3 0.0006
499 NEUTROPENIA 77 0.0006
500 PULMONARY TOXICITY 4 0.0006
501 SEASONAL ALLERGY 8 0.0006
502 RESPIRATORY RATE INCREASED 5 0.0006
503 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
504 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
505 DYSPNOEA EXERTIONAL 21 0.0006
506 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
507 LACTIC ACIDOSIS 18 0.0006
508 HAEMATURIA 19 0.0006
509 BRAIN OEDEMA 7 0.0006
510 SKIN LACERATION 6 0.0006
511 HYDROCEPHALUS 3 0.0006
512 FAECALOMA 3 0.0005
513 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
514 ASTHENOPIA 3 0.0005
515 INTESTINAL ISCHAEMIA 3 0.0005
516 ANAPHYLACTIC SHOCK 14 0.0005
517 DRUG-INDUCED LIVER INJURY 17 0.0005
518 BONE MARROW FAILURE 11 0.0005
519 MENTAL STATUS CHANGES 15 0.0005
520 LEUKOPENIA 27 0.0005
521 HEART RATE ABNORMAL 3 0.0005
522 PULMONARY MASS 8 0.0005
523 LYMPHADENOPATHY 19 0.0005
524 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
525 METABOLIC ACIDOSIS 17 0.0005
526 STATUS EPILEPTICUS 6 0.0005
527 PREMATURE LABOUR 3 0.0005
528 MITRAL VALVE INCOMPETENCE 6 0.0005
529 OROPHARYNGEAL PAIN 49 0.0005
530 CHILLS 62 0.0005
531 HYPERTONIA 3 0.0005
532 MYOCARDITIS 6 0.0005
533 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
534 HERPES VIRUS INFECTION 3 0.0005
535 POST PROCEDURAL COMPLICATION 10 0.0005
536 HAEMOLYSIS 4 0.0005
537 METABOLIC DISORDER 3 0.0005
538 NEUTROPHIL COUNT DECREASED 21 0.0005
539 EAR PAIN 10 0.0005
540 NEUROTOXICITY 9 0.0005
541 GASTROINTESTINAL DISORDER 46 0.0005
542 ACUTE HEPATIC FAILURE 7 0.0005
543 ASCITES 15 0.0005
544 ABDOMINAL PAIN UPPER 105 0.0005
545 PLEURAL EFFUSION 31 0.0005
546 DECREASED INTEREST 3 0.0005
547 MENTAL DISORDER 22 0.0005
548 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
549 NASOPHARYNGITIS 93 0.0005
550 MYOCLONUS 6 0.0005
551 ABSCESS 8 0.0005
552 HEARING IMPAIRED 3 0.0005
553 OEDEMA 27 0.0005
554 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
555 ADRENAL INSUFFICIENCY 6 0.0005
556 HYPOTENSION 99 0.0005
557 INTENTIONAL DOSE OMISSION 14 0.0005
558 BODY TEMPERATURE INCREASED 10 0.0005
559 PANCREATITIS ACUTE 11 0.0005
560 SINUSITIS 50 0.0005
561 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
562 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
563 CHOLANGITIS 3 0.0005
564 FEAR 13 0.0005
565 MENSTRUAL DISORDER 4 0.0005
566 ILEUS 6 0.0005
567 SKIN DISORDER 16 0.0005
568 NASAL DRYNESS 3 0.0005
569 WEIGHT FLUCTUATION 5 0.0005
570 RASH 208 0.0005
571 MULTIPLE INJURIES 3 0.0005
572 CARDIOMYOPATHY 7 0.0005
573 RENAL INJURY 14 0.0005
574 SCREAMING 3 0.0005
575 LETHARGY 27 0.0005
576 SEROTONIN SYNDROME 9 0.0005
577 HAEMORRHAGE INTRACRANIAL 7 0.0005
578 VITAMIN D DECREASED 4 0.0005
579 RHINORRHOEA 30 0.0005
580 DECREASED ACTIVITY 5 0.0005
581 PULMONARY THROMBOSIS 5 0.0005
582 GASTRITIS 12 0.0005
583 RHABDOMYOLYSIS 19 0.0005
584 TENDONITIS 7 0.0005
585 NERVOUS SYSTEM DISORDER 14 0.0004
586 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
587 BRAIN FOG 7 0.0004
588 GASTROINTESTINAL INFECTION 4 0.0004
589 RASH PAPULAR 10 0.0004
590 BRONCHITIS 33 0.0004
591 CYANOSIS 7 0.0004
592 PRODUCT DOSE OMISSION 29 0.0004
593 HYPERGLYCAEMIA 16 0.0004
594 ECCHYMOSIS 3 0.0004
595 BLOOD GLUCOSE DECREASED 21 0.0004
596 NEPHROLITHIASIS 20 0.0004
597 ONYCHOCLASIS 3 0.0004
598 HYPOGLYCAEMIA 21 0.0004
599 DELIRIUM 15 0.0004
600 ORAL DISCOMFORT 6 0.0004
601 VASCULITIS 5 0.0004
602 HEPATIC FUNCTION ABNORMAL 16 0.0004
603 LIVER DISORDER 19 0.0004
604 DYSPHONIA 25 0.0004
605 OFF LABEL USE 374 0.0004
606 SPLENOMEGALY 5 0.0004
607 HEPATIC CIRRHOSIS 8 0.0004
608 MANIA 7 0.0004
609 CARDIAC ARREST 35 0.0004
610 COVID-19 PNEUMONIA 5 0.0004
611 HAND FRACTURE 3 0.0004
612 UNEVALUABLE EVENT 32 0.0004
613 SINUS TACHYCARDIA 6 0.0004
614 PRODUCT PACKAGING ISSUE 4 0.0004
615 GASTRIC ULCER 8 0.0004
616 HYPERLIPIDAEMIA 5 0.0004
617 DEPRESSED MOOD 22 0.0004
618 FAECES DISCOLOURED 9 0.0004
619 SKIN EXFOLIATION 35 0.0004
620 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
621 FAECES SOFT 3 0.0004
622 FLUID OVERLOAD 6 0.0004
623 ADVERSE DRUG REACTION 37 0.0004
624 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
625 VITAMIN D DEFICIENCY 4 0.0004
626 NO THERAPEUTIC RESPONSE 5 0.0004
627 BLISTER 23 0.0004
628 FLATULENCE 23 0.0004
629 ABDOMINAL PAIN 94 0.0004
630 GENERALISED OEDEMA 5 0.0004
631 NIGHT SWEATS 13 0.0004
632 HAEMATOCRIT DECREASED 8 0.0004
633 PHARYNGITIS 5 0.0004
634 PNEUMONIA ASPIRATION 10 0.0004
635 PAROSMIA 3 0.0004
636 SLEEP DISORDER 28 0.0004
637 HAEMATEMESIS 10 0.0004
638 SLUGGISHNESS 4 0.0004
639 BOWEL MOVEMENT IRREGULARITY 3 0.0004
640 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
641 NEUTROPHIL COUNT INCREASED 4 0.0004
642 PERICARDIAL EFFUSION 9 0.0004
643 FOOD ALLERGY 3 0.0004
644 URTICARIA 65 0.0004
645 RASH PRURITIC 21 0.0004
646 TREATMENT FAILURE 32 0.0004
647 ACUTE MYELOID LEUKAEMIA 6 0.0004
648 EYE DISCHARGE 4 0.0004
649 PLATELET COUNT INCREASED 5 0.0004
650 ACCIDENTAL OVERDOSE 14 0.0004
651 TRANSFUSION 4 0.0004
652 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
653 HAEMOGLOBIN DECREASED 39 0.0004
654 PULMONARY OEDEMA 17 0.0004
655 GASTRIC DISORDER 13 0.0004
656 SARS-COV-2 TEST POSITIVE 5 0.0004
657 DRUG INTERACTION 60 0.0004
658 MIDDLE INSOMNIA 7 0.0004
659 PHOTOPHOBIA 7 0.0004
660 BLOOD SODIUM DECREASED 7 0.0004
661 OEDEMA PERIPHERAL 45 0.0004
662 CEREBRAL INFARCTION 9 0.0004
663 CHEST PAIN 68 0.0004
664 POLYURIA 3 0.0004
665 PREMATURE BABY 11 0.0004
666 ASPIRATION 4 0.0004
667 ABDOMINAL DISTENSION 38 0.0004
668 GASTROINTESTINAL PAIN 4 0.0004
669 ANGIOEDEMA 16 0.0004
670 EMBOLISM 3 0.0004
671 CYTOMEGALOVIRUS INFECTION 6 0.0004
672 EPISTAXIS 27 0.0004
673 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
674 CARDIO-RESPIRATORY ARREST 15 0.0004
675 CELLULITIS 18 0.0004
676 KIDNEY INFECTION 7 0.0004
677 SENSATION OF FOREIGN BODY 3 0.0004
678 BLOOD CALCIUM DECREASED 4 0.0004
679 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
680 HYPONATRAEMIA 20 0.0004
681 DEATH 303 0.0004
682 INTERSTITIAL LUNG DISEASE 17 0.0004
683 SCAR 6 0.0004
684 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
685 MUSCLE STRAIN 3 0.0003
686 PYELONEPHRITIS 3 0.0003
687 ANOSMIA 5 0.0003
688 WEIGHT DECREASED 96 0.0003
689 MUCOSAL INFLAMMATION 9 0.0003
690 DEPRESSION 78 0.0003
691 LYMPHOCYTE COUNT DECREASED 6 0.0003
692 BRADYCARDIA 18 0.0003
693 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
694 SUICIDAL IDEATION 31 0.0003
695 EAR INFECTION 9 0.0003
696 PERITONITIS 7 0.0003
697 PLATELET COUNT DECREASED 36 0.0003
698 CARDIOTOXICITY 3 0.0003
699 PULMONARY HYPERTENSION 7 0.0003
700 CHOLECYSTITIS 4 0.0003
701 CHOLELITHIASIS 11 0.0003
702 POLYNEUROPATHY 4 0.0003
703 LIMB INJURY 9 0.0003
704 INFLUENZA LIKE ILLNESS 27 0.0003
705 TINNITUS 15 0.0003
706 WEIGHT INCREASED 73 0.0003
707 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
708 ANAEMIA 62 0.0003
709 PHARYNGEAL OEDEMA 5 0.0003
710 IRON DEFICIENCY ANAEMIA 3 0.0003
711 EMOTIONAL DISORDER 10 0.0003
712 SWELLING FACE 21 0.0003
713 HEPATIC STEATOSIS 6 0.0003
714 CHRONIC KIDNEY DISEASE 24 0.0003
715 COMA 15 0.0003
716 RED BLOOD CELL COUNT DECREASED 9 0.0003
717 RASH MACULAR 11 0.0003
718 MALAISE 137 0.0003
719 ANOREXIA 4 0.0003
720 HAEMATOMA 8 0.0003
721 CHOKING 6 0.0003
722 ORAL CANDIDIASIS 4 0.0003
723 PANIC ATTACK 11 0.0003
724 BLOOD PRESSURE ABNORMAL 6 0.0003
725 ABORTION SPONTANEOUS 12 0.0003
726 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
727 INJURY 21 0.0003
728 JAUNDICE 8 0.0003
729 PRODUCT ADMINISTRATION ERROR 6 0.0003
730 HEADACHE 182 0.0003
731 RESPIRATORY ARREST 8 0.0003
732 URINARY TRACT INFECTION 49 0.0003
733 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
734 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
735 INJECTION SITE DISCOMFORT 3 0.0003
736 DECREASED APPETITE 66 0.0003
737 PANCREATITIS 15 0.0003
738 MOOD SWINGS 9 0.0003
739 HYPERSENSITIVITY 52 0.0003
740 PARALYSIS 4 0.0003
741 GOUT 5 0.0003
742 PHARYNGITIS STREPTOCOCCAL 3 0.0003
743 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
744 TOOTHACHE 5 0.0003
745 CONSTIPATION 60 0.0003
746 PRODUCT STORAGE ERROR 24 0.0003
747 INFLAMMATION 14 0.0003
748 SKIN ULCER 7 0.0003
749 BLOOD GLUCOSE ABNORMAL 5 0.0003
750 LIP SWELLING 9 0.0003
751 SKIN INFECTION 3 0.0003
752 ANGER 9 0.0003
753 EYE INFECTION 3 0.0003
754 FOOT FRACTURE 5 0.0003
755 OSTEOPENIA 4 0.0003
756 INSOMNIA 70 0.0003
757 DISEASE PROGRESSION 31 0.0003
758 FALL 87 0.0003
759 PULMONARY FIBROSIS 5 0.0003
760 FREQUENT BOWEL MOVEMENTS 7 0.0003
761 CAESAREAN SECTION 3 0.0003
762 DELUSION 4 0.0003
763 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
764 BLOOD PRESSURE DECREASED 17 0.0003
765 BLOOD IRON DECREASED 3 0.0003
766 ATAXIA 3 0.0003
767 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
768 ERYTHEMA 51 0.0002
769 BLOOD POTASSIUM INCREASED 4 0.0002
770 DEEP VEIN THROMBOSIS 16 0.0002
771 VERTIGO 15 0.0002
772 THERAPY NON-RESPONDER 11 0.0002
773 PRODUCT PREPARATION ERROR 5 0.0002
774 PAIN 149 0.0002
775 MIGRAINE 23 0.0002
776 HAEMORRHAGE 25 0.0002
777 PERICARDITIS 4 0.0002
778 ACNE 18 0.0002
779 MOUTH ULCERATION 5 0.0002
780 PSYCHOTIC DISORDER 7 0.0002
781 MUSCLE ATROPHY 3 0.0002
782 HYPOPHAGIA 6 0.0002
783 THERAPY CESSATION 12 0.0002
784 BLOOD POTASSIUM DECREASED 7 0.0002
785 POOR QUALITY SLEEP 5 0.0002
786 NEUROPATHY PERIPHERAL 22 0.0002
787 PRODUCT PRESCRIBING ISSUE 5 0.0002
788 LOCAL SWELLING 4 0.0002
789 COLD SWEAT 4 0.0002
790 ABDOMINAL DISCOMFORT 38 0.0002
791 HERPES ZOSTER 13 0.0002
792 HEAD DISCOMFORT 4 0.0002
793 NAUSEA 177 0.0002
794 DYSPEPSIA 22 0.0002
795 CEREBRAL HAEMORRHAGE 8 0.0002
796 DISTURBANCE IN ATTENTION 12 0.0002
797 SURGERY 13 0.0002
798 GASTROENTERITIS VIRAL 4 0.0002
799 CHROMATURIA 5 0.0002
800 DRUG TOXICITY 3 0.0002
801 CRYING 8 0.0002
802 HYPOTHYROIDISM 7 0.0002
803 VOMITING 103 0.0002
804 FEELING ABNORMAL 52 0.0002
805 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
806 COVID-19 38 0.0002
807 FLUID RETENTION 11 0.0002
808 IRRITABILITY 13 0.0002
809 COORDINATION ABNORMAL 3 0.0002
810 STOMATITIS 13 0.0002
811 DIARRHOEA 137 0.0002
812 FEELING HOT 13 0.0002
813 CARDIAC FAILURE 17 0.0002
814 COLITIS 8 0.0002
815 FATIGUE 164 0.0002
816 PULMONARY EMBOLISM 20 0.0002
817 HYPERHIDROSIS 27 0.0002
818 SUBDURAL HAEMATOMA 3 0.0002
819 HYPERTHYROIDISM 3 0.0002
820 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
821 SWELLING 19 0.0002
822 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
823 AGEUSIA 5 0.0002
824 ARTHRALGIA 83 0.0002
825 HYPOAESTHESIA ORAL 3 0.0002
826 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
827 ECONOMIC PROBLEM 3 0.0002
828 ABDOMINAL PAIN LOWER 5 0.0002
829 FEEDING DISORDER 4 0.0002
830 ASTHENIA 74 0.0002
831 INFUSION RELATED REACTION 13 0.0002
832 DRUG ADMINISTRATION ERROR 6 0.0002
833 UNRESPONSIVE TO STIMULI 5 0.0002
834 EJECTION FRACTION DECREASED 3 0.0002
835 CONVULSION 11 0.0002
836 SWOLLEN TONGUE 6 0.0002
837 ROAD TRAFFIC ACCIDENT 8 0.0002
838 AGITATION 14 0.0002
839 EATING DISORDER 4 0.0002
840 DEHYDRATION 25 0.0002
841 PRURITUS 72 0.0002
842 RECTAL HAEMORRHAGE 8 0.0002
843 CONFUSIONAL STATE 30 0.0002
844 SKIN LESION 5 0.0002
845 SEIZURE 21 0.0002
846 PHOTOSENSITIVITY REACTION 3 0.0002
847 BACK PAIN 42 0.0002
848 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
849 URINARY RETENTION 6 0.0002
850 DYSPHAGIA 17 0.0002
851 ORAL PAIN 4 0.0002
852 SNEEZING 4 0.0002
853 HEMIPARESIS 3 0.0002
854 DISORIENTATION 7 0.0002
855 PAIN IN JAW 5 0.0002
856 HYPERSOMNIA 5 0.0002
857 MUSCULOSKELETAL DISCOMFORT 3 0.0002
858 CARDIAC FAILURE CONGESTIVE 14 0.0002
859 PARANOIA 3 0.0002
860 MUSCLE TWITCHING 4 0.0002
861 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
862 RENAL DISORDER 8 0.0002
863 AMENORRHOEA 3 0.0002
864 OSTEOPOROSIS 7 0.0002
865 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
866 DISEASE RECURRENCE 8 0.0002
867 GALLBLADDER DISORDER 3 0.0002
868 JOINT SWELLING 20 0.0002
869 LACRIMATION INCREASED 5 0.0002
870 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
871 OSTEOARTHRITIS 7 0.0002
872 MENTAL IMPAIRMENT 4 0.0002
873 BONE DISORDER 3 0.0002
874 FIBROMYALGIA 4 0.0002
875 CONJUNCTIVITIS 3 0.0002
876 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
877 PRODUCT USE ISSUE 30 0.0002
878 DYSARTHRIA 6 0.0002
879 SOMNOLENCE 32 0.0002
880 DIZZINESS 79 0.0002
881 HEPATITIS 4 0.0002
882 HERNIA 3 0.0002
883 DIPLOPIA 4 0.0002
884 AMNESIA 10 0.0002
885 MENORRHAGIA 3 0.0002
886 IMPAIRED HEALING 5 0.0002
887 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
888 ABNORMAL BEHAVIOUR 6 0.0002
889 DRUG INEFFECTIVE 196 0.0001
890 PRODUCT PHYSICAL ISSUE 3 0.0001
891 ARRHYTHMIA 7 0.0001
892 MOOD ALTERED 4 0.0001
893 PARAESTHESIA 23 0.0001
894 HALLUCINATION, VISUAL 3 0.0001
895 HYPERTENSION 30 0.0001
896 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
897 RETCHING 3 0.0001
898 TREMOR 23 0.0001
899 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
900 MELAENA 3 0.0001
901 LABORATORY TEST ABNORMAL 4 0.0001
902 URINARY INCONTINENCE 4 0.0001
903 HEPATOTOXICITY 3 0.0001
904 GLOSSODYNIA 3 0.0001
905 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
906 HEART RATE IRREGULAR 3 0.0001
907 HALLUCINATION 10 0.0001
908 LOSS OF CONSCIOUSNESS 17 0.0001
909 PRODUCT DOSE OMISSION ISSUE 39 0.0001
910 APHASIA 4 0.0001
911 SYNCOPE 13 0.0001
912 LIMB DISCOMFORT 4 0.0001
913 BURNING SENSATION 9 0.0001
914 ARTHRITIS 10 0.0001
915 HEAD INJURY 4 0.0001
916 MEDICATION ERROR 7 0.0001
917 NEURALGIA 3 0.0001
918 MUSCULAR WEAKNESS 14 0.0001
919 DYSKINESIA 5 0.0001
920 ALOPECIA 24 0.0001
921 BLOOD GLUCOSE INCREASED 23 0.0001
922 ABASIA 3 0.0001
923 OSTEONECROSIS OF JAW 3 0.0001
924 VISUAL IMPAIRMENT 15 0.0001
925 DRUG DOSE OMISSION 20 0.0001
926 DRY EYE 6 0.0001
927 GAIT INABILITY 4 0.0001
928 EYE PRURITUS 4 0.0001
929 EXPOSURE VIA SKIN CONTACT 3 0.0001
930 NIGHTMARE 4 0.0001
931 SPEECH DISORDER 6 0.0001
932 MUSCULOSKELETAL STIFFNESS 10 0.0001
933 HEART RATE DECREASED 4 0.0001
934 MYELOSUPPRESSION 4 0.0001
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
936 VISION BLURRED 15 0.0001
937 ABNORMAL DREAMS 3 0.0001
938 PROCEDURAL PAIN 3 0.0001
939 EYE SWELLING 4 0.0001
940 EMOTIONAL DISTRESS 13 0.0001
941 BREAST CANCER 10 0.0001
942 BLOOD CHOLESTEROL INCREASED 5 0.0001
943 HOT FLUSH 8 0.0001
944 PERIPHERAL SWELLING 16 0.0001
945 THROMBOSIS 8 0.0001
946 DYSGEUSIA 7 0.0001
947 HYPOACUSIS 4 0.0001
948 BALANCE DISORDER 8 0.0001
949 DEVICE DISLOCATION 4 0.0001
950 PAIN IN EXTREMITY 27 0.0001
951 ARTHROPATHY 5 0.0001
952 DEVICE ISSUE 8 0.0001
953 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
954 MEMORY IMPAIRMENT 12 0.0001
955 SKIN DISCOLOURATION 4 0.0001
956 BONE PAIN 5 0.0001
957 OCULAR HYPERAEMIA 4 0.0001
958 THERAPY INTERRUPTED 6 0.0001
959 DIABETES MELLITUS 6 0.0001
960 FLUSHING 8 0.0001
961 MUSCULOSKELETAL PAIN 4 0.0001
962 DRY SKIN 10 0.0001
963 NEOPLASM MALIGNANT 5 0.0001
964 EXTRA DOSE ADMINISTERED 3 0.0001
965 DRY MOUTH 6 0.0001
966 HYPOAESTHESIA 11 0.0001
967 GAIT DISTURBANCE 14 0.0001
968 CONTUSION 7 0.0001
969 HAEMATOCHEZIA 4 0.0001
970 DEVICE MALFUNCTION 5 0.0001
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
972 DRUG WITHDRAWAL SYNDROME 6 0.0001
973 SUICIDE ATTEMPT 4 0.0001
974 TOXICITY TO VARIOUS AGENTS 11 0.0001
975 COGNITIVE DISORDER 3 0.0001
976 CARDIAC DISORDER 6 0.0001
977 CEREBROVASCULAR ACCIDENT 10 0.0001
978 NO ADVERSE EVENT 10 0.0001
979 MUSCLE SPASMS 10 0.0001
980 ADVERSE EVENT 5 0.0001
981 CATARACT 3 0.0001
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
983 INCORRECT DOSE ADMINISTERED 11 0.0000
984 INTENTIONAL PRODUCT MISUSE 4 0.0000
985 PRODUCT QUALITY ISSUE 5 0.0000
986 RHEUMATOID ARTHRITIS 4 0.0000
987 MYOCARDIAL INFARCTION 6 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
989 OVERDOSE 6 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
991 INJECTION SITE ERYTHEMA 3 0.0000
992 PSORIASIS 3 0.0000